Northern Trust Corp Navidea Biopharmaceuticals, Inc. Transaction History

Northern Trust Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	BUY	$1.99 - $2.9 $1,195 - $1,742	601 Added 1.55%	39,414 $80,000
Q4 2020 Feb 11, 2021	BUY	$1.88 - $2.84 $5,305 - $8,014	2,822 Added 7.84%	38,813 $83,000
Q3 2020 Nov 16, 2020	SELL	$2.69 - $4.95 $26,370 - $48,524	-9,803 Reduced 21.41%	35,991 $97,000
Q2 2020 Aug 14, 2020	BUY	$0.7 - $4.16 $16,690 - $99,186	23,843 Added 108.62%	45,794 $180,000
Q4 2019 Feb 14, 2020	BUY	$0.65 - $1.26 $6,316 - $12,243	9,717 Added 79.43%	21,951 $27,000
Q2 2019 Aug 13, 2019	BUY	$0.62 - $3.6 $7,585 - $44,042	12,234 New	12,234 $8,000

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.